NAOV - NanoVibronix raises 'bought deal' offering to $1.8M

Due to demand, NanoVibronix's (NAOV) underwriter has agreed to increase the size of the previous public offering ($1.5M) and purchase on a firm commitment basis 1,794,783 common shares at $1.00/share, for expected gross proceeds of ~$1.8M.Underwriter's over-allotment is an additional 269,217 shares. Net proceeds will be used for working capital and other general corporate purposes.H.C. Wainwright & Co. is acting as the sole book-running manager.Closing date is September 25.The shares rocketed 103% during the regular session, following the news of FDA authorization of UroShield.Yesterday's close was $1.20. Shares down 13% after-hours.See Company's ownership structure below:

For further details see:

NanoVibronix raises 'bought deal' offering to $1.8M